t

MSH|^~\&|SendingApp|SendingFac|ReceivingApp|ReceivingFac|20150323144246||ORU^R01|91734|P|2.5.1
SFT|ST^A^1^2^ISO^String&String&DNS^AM^String&String&DNS^P^String|String|String|String|String
PID|1||6010022||SOFTTEST^HIECLIENT||19650601|F||||||||||60100222016
PV1|1|O|1893^^^ZHIE||||4098^Physician^Sheldon|4098^Physician^Sheldon|||||||||4098^Physician^Sheldon|R||||||||||||||||||||||||||201503201114
ORC|RE|528527425|56083|||||||||4098^Physician^Sheldon^A
OBR|1|528527425|CTG150000145|LAB6460^Gene Bone Marrow||201503201114|201503231500|||||||201503231629||4098^Physician^Sheldon^^^^MD||||||201503231637||CTG|F||1
OBX|1|TX|LAB6460^Gene Bone Marrow||||||||||||RWBH
OBX|2|TX|LAB6460^Gene Bone Marrow||||||||||||RWBH
NTE|1||Physician: SHELDON A PHYSICIAN, MD
NTE|2||  NPI: 1881654887
NTE|3||Location: Oakland Medical Group III
NTE|4||    Loc ID: 1893
NTE|5
NTE|6||Collected: 3/23/2015 3:00 PM Received: 3/23/2015
NTE|7|| 4:29 PM Lab      642000066
NTE|8||
NTE|9||        Order#:
NTE|10
NTE|11||Clinical History: Testing field shows all data
NTE|12|| typed
NTE|13||CTG-15-145
NTE|14||
NTE|15
NTE|16||Specimen Type:               Bone Marrow No. of
NTE|17|| Cells Counted:  20
NTE|18||Modal Chromosome Number:     46          No. of
NTE|19|| Cells Analyzed: 20
NTE|20||No. and/or Type of Cultures: ST
NTE|21|| Hypermodal Cells:      0
NTE|22||Staining Method:             GTL
NTE|23|| Hypomodal Cells:       0
NTE|24||Band Level:                  400-450     No. of
NTE|25|| Karyotypes:     3
NTE|26
NTE|27||KARYOTYPE:      46,XX[20]
NTE|28||
NTE|29
NTE|30||CYTOGENETIC DIAGNOSIS:        Normal Female
NTE|31|| Chromosome Complement
NTE|32
NTE|33||INTERPRETATION: Cytogenetic examination of twenty
NTE|34|| metaphase cells revealed a
NTE|35||normal female diploid karyotype with no
NTE|36|| consistent numerical or structural
NTE|37||chromosome aberrations observed. This chromosome
NTE|38|| study does not eliminate the
NTE|39||possibility of single gene defects, chromosomal
NTE|40|| mosaicism involving abnormal
NTE|41||cell lines of low frequency, small structural
NTE|42|| chromosome abnormalities, or
NTE|43||failure to sample any malignant clones(s) that
NTE|44|| may be present.
NTE|45
NTE|46||Test Person NODOC
NTE|47||
NTE|48||Medical Director, Clinical Cytogenomics
NTE|49|| Laboratory
NTE|50||Board Certified Clinical Cytogeneticist/Clinical
NTE|51|| Molecular Geneticist
NTE|52||3/23/2015 4:37 PM
NTE|53||
NTE|54||All results from conventional karyotyping,
NTE|55|| molecular cytogenetics (FISH), and
NTE|56||chromosome microarray studies, as well as the
NTE|57|| final report, have been reviewed
NTE|58||by a staff cytogeneticist.
NTE|59||
OBR|1||12376|cbc^CBC|R||20120410160227|||22^GOOF^GOOFY|||Fasting: No|201204101625||71^DUCK^DONALD||||||201204101630|||F||^^^^^R|||||||||||||||||85025|
OBX|1|NM|wbc^Wbc^Local^6690-2^Wbc^LN||7.0|/nl|3.8-11.0||||F|||20120410160227|lab|12^XYZ LAB|
OBX|2|NM|neutros^Neutros^Local^770-8^Neutros^LN||68|%|40-82||||F|||20120410160227|lab|12^XYZ LAB|
OBX|3|NM|lymphs^Lymphs^Local^736-9^Lymphs^LN||20|%|11-47||||F|||20120410160227|lab|12^XYZ LAB|
OBX|4|NM|monos^Monos^Local^5905-5^Monos^LN||16|%|4-15|H|||F|||20120410160227|lab|12^XYZ LAB|
OBX|5|NM|eo^Eos^Local^713-8^Eos^LN||3|%|0-8||||F|||20120410160227|lab|12^XYZ LAB|
OBX|6|NM|baso^Baso^Local^706-2^Baso^LN||0|%|0-1||||F|||20120410160227|lab|12^XYZ LAB|
OBX|7|NM|ig^Imm Gran^Local^38518-7^Imm Gran^LN||0|%|0-2||||F|||20120410160227|lab|12^XYZ LAB|
OBX|8|NM|rbc^Rbc^Local^789-8^Rbc^LN||4.02|/pl|4.07-4.92|L|||F|||20120410160227|lab|12^XYZ LAB|
OBX|9|NM|hgb^Hgb^Local^718-7^Hgb^LN||13.7|g/dl|12.0-14.1||||F|||20120410160227|lab|12^XYZ LAB|
OBX|10|NM|hct^Hct^Local^4544-3^Hct^LN||40|%|34-43||||F|||20120410160227|lab|12^XYZ LAB|
OBX|11|NM|mcv^Mcv^Local^787-2^Mcv^LN||80|fl|77-98||||F|||20120410160227|lab|12^XYZ LAB|
OBX|12|NM|mch^Mch||30|pg|27-35||||F|||20120410160227|lab|12^XYZ LAB|
OBX|13|NM|mchc^Mchc||32|g/dl|32-35||||F|||20120410160227|lab|12^XYZ LAB|
OBX|14|NM|plt^Platelets||221|/nl|140-400||||F|||20120410160227|lab|12^XYZ LAB|